British Cannabis
British Cannabis is a UK-based, vertically integrated manufacturer and distributor of CBD and medical cannabis products, operating since 2015 through four brands across prescription clinical, pharmacy, consumer e-commerce, and B2B white-label channels from its Wokingham headquarters.
- Company typePrivate
- Founded2015
- HeadquartersWokingham, United Kingdom
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What British Cannabis does
British Cannabis, operating through its legal entity BIGLOVE.AI LTD, is a UK-based vertically integrated manufacturer and distributor of CBD and cannabis-derived products founded in 2015 and headquartered in Wokingham, England. The company controls the full value chain from cannabis cultivation (indoor, outdoor, germination, cloning) through extraction (proprietary ethanol extraction combined with steam distillation for terpenes, plus an environmentally friendly cold-press method) to manufacturing, packaging, and retail distribution. Its product architecture centers on strain-specific sublingual oils featuring eight unique cannabis cultivars with preserved terpene profiles, available in precise THC (2mg and 5mg per 0.1mL) and CBD (5mg per 0.1mL) doses, and operates the largest cannabis extraction and purification facility in England.
The company monetizes through a multi-brand portfolio targeting distinct price tiers and channels: BRITISH CANNABIS™ Medicines for prescription clinical use, CBD by BRITISH CANNABIS™ as the premium pharmacy range (Pharmacy Product of the Year), ACCESS CBD® for affordable consumer products, and Canabidol™ as an established brand. Revenue is generated across four primary streams: direct-to-consumer e-commerce through three owned storefronts (britishcannabis.org, accesscbd.uk, canabidol.com), wholesale distribution to retailers, white-label manufacturing and bulk CBD ingredient supply to other UK brands, and prescription medical cannabis sales through clinical channels. Customer segments include individual wellness consumers, medical cannabis patients, healthcare professionals and pharmacies, and B2B white-label/wholesale partners. Distribution covers the UK plus 30+ international markets across the EU, North America, Asia, South America, Africa, and Australasia (excluding the US due to compliance constraints).
The business is privately held with no disclosed external funding rounds or institutional investors, operates with 11-50 employees, and has positioned itself as a category leader through brand heritage (since 2015), self-claimed status as the UK's largest CBD producer and most prescribed medical cannabis oil brand, and multi-channel credibility signals including Trustpilot reviews (4,800+ for ACCESS CBD), Made in Britain certification, an exclusive partnership with TV health campaigner Dr. Christian Jessen, and a carbon-neutral operations partnership with Earthly.
British Cannabis firmographics
Firmographics- Name
- British Cannabis
- Legal name
- BIGLOVE.AI LTD
- Website
- https://britishcannabis.org
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- British Cannabis is a UK-based, vertically integrated manufacturer and distributor of CBD and medical cannabis products, operating since 2015 through four brands across prescription clinical, pharmacy, consumer e-commerce, and B2B white-label channels from its Wokingham headquarters.
- Ownership category
- akta.pro rank
British Cannabis industry classification
Industry- Product category
- Cannabis-derived CBD and medical cannabis products
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)
- akta.pro secondary industries
- On-Demand Cannabis Delivery (Courier-to-Consumer) (CRANAGAA), Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH), Medical Cannabis Delivery & Online Ordering (CRANAGAG)
Keywords
Where British Cannabis is headquartered
LocationHeadquarters
- HQ city
- Wokingham
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
British Cannabis business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Direct E-commerce Sales: B2C sales through owned e-commerce storefronts (britishcannabis.org, accesscbd.uk, canabidol.com) selling CBD oils, gummies, capsules, topicals, and vape products directly to consumers.
- White Label Manufacturing: Provides analytical testing, bulk CBD extracts, and white-label CBD products to UK market-leading brands. Owns and operates the largest cannabis extraction and purification facility in England.
- Wholesale Distribution: Wholesale distribution of CBD products and bulk CBD ingredients to retailers and other businesses.
- Medical Cannabis Prescription: Prescription-only medical cannabis oils (2THC and 5THC branded products) distributed through clinical channels to patients with prescriptions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Strain-Specific 5CBD Oils (500mg, 10ml) |
| Unit Pricing | Pay-as-you-go | RAW 100% Cannabis Oil Range |
| Unit Pricing | Pay-as-you-go | ACCESS CBD Oil Range (30ml) |
| Unit Pricing | Pay-as-you-go | ACCESS CBD Gummies Range |
| Unit Pricing | Pay-as-you-go | Refined 100% Cannabis Oil |
| Other | Multi-year contract | Bulk and White Label Services |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
British Cannabis product offering
Product offeringCore offering
British Cannabis manufactures and distributes a multi-brand portfolio of cannabis-derived CBD food supplements, medical cannabis prescription oils, and skincare/topical products, alongside B2B white-label manufacturing, bulk CBD ingredients, and cannabis extraction services. The company operates the largest dedicated cannabis extraction and purification facility in England, with vertically integrated cultivation, extraction, formulation, and distribution capabilities serving UK, EU, and select international markets.
Product overview
British Cannabis operates as a comprehensive CBD and medicinal cannabis company offering a multi-brand portfolio across consumer and medical channels. The core offering includes three main sub-brands: ACCESS CBD® (affordable consumer products), CBD by BRITISH CANNABIS™ (premium pharmacy-range products), and BRITISH CANNABIS™ Medicines (prescription-only medical cannabis oils). The product range spans CBD oils (in various spectrums and strengths from 250mg to 4800mg), gummies, capsules, topical creams and patches, vape products, and functional foods. The company also operates B2B services including white label manufacturing, bulk CBD ingredients, and extraction services. British Cannabis is vertically integrated, controlling cultivation, extraction, manufacturing, and distribution, with stated operations in the UK since 2015. The company emphasizes strain-specific formulations leveraging the entourage effect through preserved terpene profiles.
Differentiator
Problem solved
Functional benefit
Brands
- ACCESS CBD®: Affordable CBD products at accessible prices with fruity flavours and clear dosage.
- CBD by BRITISH CANNABIS™
- BRITISH CANNABIS™ Medicines
- 5CBD™
- 2THC™
- 5THC™
Products and services
- ACCESS CBD® Range Budget-friendly CBD consumer product line featuring oils, gummies, capsules, and supplements in Natural, Berry, and Citrus flavours with strengths ranging from 250mg to 4800mg. Targeted at general consumers seeking value-priced, lab-tested CBD supplements for daily wellness.
- CBD by BRITISH CANNABIS™ (Pharmacy Range) Premium 100% cannabis CBD oils (RAW unrefined and Refined broad spectrum) in strengths from 250mg to 2000mg, including the RAW 100% Cannabis Oil range. Distributed through UK pharmacies; contains no isolates or fillers, only full cannabis extract.
- BRITISH CANNABIS™ Medicines (2THC™ and 5THC™) Prescription-only medical cannabis sublingual oils available in 2THC (2mg THC per 0.1mL) and 5THC (5mg THC per 0.1mL) variants, plus 5CBD (5mg CBD per 0.1mL) for non-prescription access. Features eight strain-specific terpene profiles for tailored therapeutic outcomes and precise titration dosing. Distributed via specialist doctors and clinical channels.
- 5CBD™ Strain-Specific CBD Oils Full-plant extract CBD oils in 500mg/10ml strength across eight strain-specific varieties with authentic cannabis-derived terpenes preserved through advanced extraction. Available without prescription at £49.99 per bottle, offering medical-grade strain specificity for consumer wellness use.
- CBD Gummies Edible CBD gummies in Berry and Citrus flavours with strengths from 250mg to 1500mg, available in both THC-free and full-spectrum options. Suitable for vegans with natural terpenes, priced from £8.99 to £38.99.
- CBD Capsules Capsule-form CBD supplements providing convenient, discreet consumption with precise per-unit dosing for consumers seeking a non-oil delivery format.
- CBD Skincare and Creams (CBD RESCUE CREAM®) Topical CBD products including the 250mg CBD RESCUE CREAM® designed for dermal application, providing targeted relief through skin absorption for joint, muscle, and localized discomfort.
- CBD Patches Transdermal CBD patches available in 30-pack and 50-pack formats providing sustained release of 50mg CBD per patch through skin absorption for extended therapeutic effects over time.
- BRITISH CANNABIS™ Vape Range (Pods and 510 Cartridges) New BRITISH CANNABIS™ vape range featuring pods and 510 cartridges with strain-specific cannabis formulations for rapid onset effects. Designed for adult consumers seeking a cannabis-inspired vapor format.
- White Label CBD Services B2B contract manufacturing service enabling other brands to launch their own CBD product lines using British Cannabis's extraction facility, formulation expertise, and packaging capabilities. Quote-based multi-year contract pricing for UK market-leading brands.
- Bulk CBD Ingredients B2B wholesale supply of bulk CBD extracts and raw ingredients to other manufacturers and brands in the UK CBD industry. Sourced from the largest cannabis extraction and purification facility in England.
- Cannabis Extraction Services Professional cannabis extraction and purification services combining ethanol extraction for crude extract and steam distillation for terpene recovery. Operated from the largest dedicated cannabis extraction and purification facility in England for B2B partners.
- Laboratory Testing and Certificates of Analysis Analytical testing services providing Certificates of Analysis (COA) documenting product purity, potency, and contaminant screening for every batch, supporting compliance and transparency for both internal products and B2B partners.
Quantifiable outcome
- Rapid onset within 15-30 minutes for sublingual oils
- +3 more outcomes
Companies that use British Cannabis
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
British Cannabis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
British Cannabis partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- EarthlycorePartnership with Earthly, a nature-based solutions organization, to achieve carbon-neutral operations. Earthly evaluates British Cannabis across 106 data points including BeZero and Google Earth Engine inputs. The partnership removes over 110% of carbon created through science-backed projects including kelp farms in UK and rainforests in Peru.
- Dr. Christian JessencoreExclusive CBD GUIDE partnership with TV health campaigner Dr. Christian Jessen, providing expert endorsement and educational content for the British Cannabis brand. Features Dr. Jessen in CBD Guide materials and buyer guides.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
British Cannabis competitors and assessment
Company assessmentDirect peers
- Endoca: European CBD manufacturer and brand with vertically integrated hemp cultivation, extraction, and global DTC/retail sales. Closely comparable to British Cannabis on the vertical-integration manufacturing thesis and broad-spectrum extract product range.
- Charlotte's Web Holdings: US-listed CBD wellness brand built around proprietary full-spectrum hemp extracts and brand-led distribution. Comparable on full-spectrum formulation positioning, brand-led consumer franchise, and extract-based product architecture.
- Dragonfly CBD: UK CBD brand with broad consumer range across oils, gummies, capsules, and topicals distributed through UK retailers and own e-commerce. Directly comparable in product breadth, UK retail presence, and DTC-first go-to-market motion.
- Love Hemp: UK-based CBD consumer brand offering oils, capsules, gummies, and topicals through DTC and retail channels. Closely comparable in product mix, UK-centric DTC model, and premium positioning to British Cannabis's ACCESS CBD and CBD by British Cannabis lines.
- CV Sciences: US-based CBD consumer products company plus pharmaceutical pipeline development, including a drug-development unit focused on cannabinoid therapeutics. Comparable in pairing consumer CBD distribution with clinical/medical positioning, mirroring British Cannabis's ACCESS CBD plus BRITISH CANNABIS Medicines split.
- Cannaray: UK premium CBD wellness brand selling oils, skincare, and capsules via DTC and major UK retailers. Comparable to British Cannabis on multi-channel UK distribution, premium positioning, and broad consumer SKU portfolio.
- Elixinol: Global CBD brand and ingredient supplier with full-spectrum hemp extracts sold DTC and B2B across multiple markets. Comparable to British Cannabis on the dual consumer-brand plus B2B bulk-ingredient business model.
Broad incumbents
- Jazz Pharmaceuticals (GW Pharmaceuticals): Global specialty pharma that acquired GW Pharmaceuticals and its cannabis-derived prescription drug portfolio (Sativex, Epidiolex). Comparable as the established cannabis-pharma incumbent that validates prescription cannabinoid economics that British Cannabis's medical division is targeting.
- Curaleaf Holdings: US multi-state cannabis operator with cultivation, processing, and retail across medical and adult-use. Comparable as a broad incumbent in cannabis manufacturing and distribution, though operating a different regulatory and channel mix than British Cannabis's UK base.
- Tilray Brands: Global cannabis and wellness operator with medical, consumer, and B2B ingredient businesses across multiple geographies. Comparable as a large-scale vertically integrated cannabis manufacturer and distributor with a broader international footprint than British Cannabis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
British Cannabis social profiles
Digital presenceBritish Cannabis financial estimates
Financial estimateRevenue estimate
Valuation estimate
British Cannabis leadership team
Management profileNumber of profiles
British Cannabis subsidiaries and ownership
Company hierarchySubsidiaries1 record
British Cannabis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
British Cannabis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about British Cannabis
What does British Cannabis do?
British Cannabis manufactures and distributes a multi-brand portfolio of cannabis-derived CBD food supplements, medical cannabis prescription oils, and skincare/topical products, alongside B2B white-label manufacturing, bulk CBD ingredients, and cannabis extraction services. The company operates the largest dedicated cannabis extraction and purification facility in England, with vertically integrated cultivation, extraction, formulation, and distribution capabilities serving UK, EU, and select international markets.
Is British Cannabis a public or private company?
British Cannabis is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was British Cannabis founded?
British Cannabis was founded in 2015. It employs 11 to 50 people.
Where is British Cannabis based?
British Cannabis is headquartered in Wokingham, United Kingdom, in the Europe region.
How does British Cannabis make money?
Four revenue lines are on record. Direct E-commerce Sales are the primary driver. The others are white Label Manufacturing, wholesale Distribution and medical Cannabis Prescription.
Who are British Cannabis's main competitors?
Direct peers on record are Endoca, Charlotte's Web Holdings, Dragonfly CBD, Love Hemp, CV Sciences, Cannaray and Elixinol. Broad incumbents are Jazz Pharmaceuticals (GW Pharmaceuticals), Curaleaf Holdings and Tilray Brands.
Does British Cannabis have an API?
No public API is recorded for British Cannabis.
What industry is British Cannabis in?
British Cannabis's product category is Cannabis-derived CBD and medical cannabis products. Its primary akta.pro industry code is CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles), with a secondary code of CRANAGAA, On-Demand Cannabis Delivery (Courier-to-Consumer). Its NAICS code is 325411 and its SIC code is 2833.